IVERIC bio (ISEE) Misses Q2 EPS by 11c

IVERIC bio (NASDAQ: ISEE) reported Q2 EPS of ($0.41), $0.11 worse than the analyst estimate of ($0.30).

As of June 30, 2022, the Company had $312 million in cash, cash equivalents and available for sale securities.

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Reading (RDI) Tops Q2 EPS by 4c